Table of Contents Table of Contents
Previous Page  5 / 25 Next Page
Information
Show Menu
Previous Page 5 / 25 Next Page
Page Background

MECANISMO ACCIÓN LENVATINIB

BRAF

CRAF

RAS

MEK

ERK

mTOR

PI3K

TSC2

ATK

Nucleus

Cytoplasm

Gene expression

Cell proliferation

Differentiation

Apoptosis

Growth Factor Receptors

(VEGFR, FGFR, PDGFR, RET)

Growth Factors

(VEGF, FGF, PDGF, GDNF)

S6K

PTEN

Angiogenesis

Survival

Tumour Cell

Tumour Endothelial Cell or Pericyte

FGFR

VEGFR

PDGFR

FGF

VEGF

PDGF

HIF

RAS

MEK

ERK

Apoptosis

Nucleus

Gene expression

Cytoplasm

RAF

mTOR

PI3K

ATK

S6K

PTEN

Angiogenesis

Differentiation

Proliferation

Migration

Tubule formation

Lenvatinib

Lenvatinib